Transvaginal Mesh Infection
In a health alert issued on October 28, 2008, the FDA stated that, over the last three years, it has received more than 1,000 reports from nine surgical mesh manufacturers of complications that were associated with surgical mesh devices used to repair Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). One of the most frequent transvaginal surgical mesh complications reported to the FDA was serious infection. As a result, our lawyers believe that there should be a Bard Avaulta surgical mesh recall.
Causes of Transvaginal Mesh Infections
Infections from transvaginal placement of surgical mesh are reported to most likely occur in one of two ways. First, an infection may be caused by bowel, bladder, or blood vessel perforation which occurs during insertion of the surgical mesh. Second, the surgical mesh design may inhibit surrounding tissue from receiving nutrients and oxygen, causing impaired healing, which can lead to an infection.
- Bard Avaulta Mesh Side Effects
- Avaulta Biosynthetic & Avaulta Plus Biosynthetic Support Systems
- Bard Avaulta Mesh Lawyer Lawsuit
- Bard Transvaginal Mesh Recall
- Bard Avaulta Mesh Corrective Measures
- Cystocele &Transvaginal Mesh
- Bard Avaulta Mesh & Dyspareunia
- Bard Avaulta Mesh Erosion
- Bard Avaulta Mesh Pelvic Organ Prolapse
- Bard Avaulta Mesh Stress Urinary Incontinence
- Transvaginal Mesh & Vaginal Prolapse
Dangerous Product Alerts
Similar Defective Devices
The FDA has not yet determined whether specific characteristics put some patients at an increased risk for infection from transvaginal surgical mesh. Contributing factors may include the patient’s overall health, the transvaginal surgical mesh material, the size and shape of the surgical mesh, the surgical technique used, concomitant procedures undertaken (e.g. hysterectomy), and possibly estrogen status.
Treatment of infections associated with transvaginal placement of surgical mesh may require additional surgical procedures (some of them to remove the transvaginal mesh), IV therapy, blood transfusions, and drainage of hematomas or abscesses.
Reporting Transvaginal Mesh Infections
To help the FDA learn more about possible problems, including infections, with transvaginal placement of surgical mesh, physicians and patients are strongly encouraged to report infections and other complications associated with this device to the FDA’s MedWatch Adverse Event Reporting Program.
Transvaginal Mesh Infection Attorneys
The Bard Avaulta surgical mesh attorneys at our law firm believe that defective surgical mesh may contribute to causing infections. If you or a loved one has experienced a serious side effect associated with transvaginal placement of surgical mesh, such as infection, you may be entitled to compensation for your injuries. Contact our law firm today for a confidential and free case evaluation.